Market Brief

The articles are produced in Chinese only.


研究部 (Research Team)


香港槓桿及反向產品介紹——南方東英恒生指數每日反向(-1x) 產品 (7300.HK)

Friday, October 18, 2019 Views1536


槓桿及反向產品(Leveraged and Inverse Products,L&I Products)是一種採用基金結構的衍生產品。投资者可在香港聯合交易所有限公司(聯交所)買賣有關產品的股份/單位。





每日重新平衡(daily rebalancing):為實現其投資目標,槓桿及反向產品須每日重新平衡其投資組合,令槓桿倍數保持特定水平。


南方東英恒生指數每日反向(-1x) 產品 (7300.HK

基本資料:南方東英恒生指數每日反向(-1x) 產品是以期貨為基礎的產品 ,直接投資於在香港期貨交易所有限公司上市的恒生指數期貨合約,目的是使該產品有恒生指數每日反向表現 (-1x)。 這是一個反向ETF,與傳統的交易所買賣基金不同。如指數的相關證券增值,可能對該ETF的表現有負面的影響。在若干情況下(包括牛市),單位持有人可能就該等投資面臨極低回報或零回報,或甚至蒙受全盤損失。

技術分析:7300.HK 10月以來跌穿10天、20天和50天線,10月17日收市價為5.46元。近日中美貿易談判的利好消息可能使恆指再往上衝,則有可能進一步下試5.40元。若恆指回軟,則有可能上試5.75元。

This report is produced and is being distributed in Hong Kong by Phillip Securities Group with the Securities and Futures Commission (“SFC”) licence under Phillip Securities (HK) LTD and/ or Phillip Commodities (HK) LTD (“Phillip”). Information contained herein is based on sources that Phillip believed to be accurate. Phillip does not bear responsibility for any loss occasioned by reliance placed upon the contents hereof. The information is for informative purposes only and is not intended to or create/induce the creation of any binding legal relations. The information provided do not constitute investment advice, solicitation, purchase or sell any investment product(s). Investments are subject to investment risks including possible loss of the principal amount invested. You should refer to your Financial Advisor for investment advice based on your investment experience, financial situation, any of your particular needs and risk preference. For details of different product's risks, please visit the Risk Disclosures Statement on Phillip (or employees) may have positions/ interests in relevant investment products. Phillip (or one of its affiliates) may from time to time provide services for, or solicit services or other business from, any company mentioned in this report. The above information is owned by Phillip and protected by copyright and intellectual property Laws. It may not be reproduced, distributed or published for any purpose without prior written consent from Phillip.
Top of Page
Contact Us
Please contact your account executive or call us now.
Research Department
Tel : (852) 2277 6846
Fax : (852) 2277 6565
Email :

Enquiry & Support
The Complaint Procedures
Louis Talk
Investor Notes
Free Subscribe
Contact Us